The European Commission granted an approval under exceptional circumstances to InflaRx’s immunosuppressant. The European ...

San Francisco’s public health director, who oversaw the city’s responses to the COVID-19 pandemic and fentanyl crisis, ...

InflaRx (IFRX) has received EU regulatory approval for its treatment Gohibic for the treatment of COVID-19 patients ...

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look ...

An attorney for Keith Middlebrook said they would appeal and called Magic Johnson, who testified during trial, "the biggest ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

The second possibility is that Covid has now settled into a rut, which will see it become progressively milder until it ...

Starmer’s Labour government is risking patient safety by shifting burdens instead of solving systemic issues. Though he ...

Challenge trials help researchers study immune responses. Skeptics still doubt the approach is worth the risks ...

An Orange County man and part-time actor, was sentenced to 98 months in federal prison for soliciting investors in companies ...